Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Read about user experiences with no fee travel points cards. Gain insights to enhance your travel rewards journey!
17,260 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
This article breaks down everquote (ever) 2025 earnings with a clear, investor-focused lens. Learn the key metrics to...
Investing in Nexpoint Residential (NXRT) hinges on understanding earnings beyond headline numbers. This guide breaks ...
Lowe’s beat on near-term earnings but issued a muted FY26 outlook, sending its stock lower while TJX jumped on strong...
Lemonade posted first positive GAAP free cash flow in the latest quarter, a milestone that reshapes the insurtech nar...
Airgain's 2025 earnings outlook hinges on product mix, OEM momentum, and margin discipline. This guide breaks down th...
The Meta deal lights up new questions about AMD's growth path and dilution risk. This guide breaks down what the 6 gi...
Fresh NAEP data in early 2026 shows a broad but nuanced slide in reading and math for 4th and 8th graders, renewing d...
Amazon has faced headwinds and briefly dipped below $200. This guide explains how to evaluate a dip, set targets, and...
A new institutional stake in Telephone and Data Systems has sparked questions about its implications. This guide expl...
A practical guide to understanding Fuel Tech (FTEK) in 2025. Learn what to watch in Q4 results, identify catalysts, a...
As Toro prepares to report and discuss its 2026 earnings, investors want clarity on demand, margins, and guidance. Th...